Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07139067 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors

Study acronym: YK1101
StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 24, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
A single-arm, open-label, dose exploratory study to evaluate the safety, efficacy, and pharmacokinetics of autologous humanized anti-MAGE-A4 T cell receptor-engineered T cell (TCR-T) in advanced solid tumors.
Trial Details
NCT Number NCT07139067
Lead Sponsor Peking University
Collaborators: Yingkai Saiwei（Beijing）Biotechnology Co., Ltd
Conditions
(from sponsor)		 Advanced Solid Tumor Cancer
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov